nutrients-logo

Journal Browser

Journal Browser

Nutrition and Obesity Management in Prader-Willi Syndrome and Other Forms of Genetic Obesity

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutrition and Public Health".

Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 3850

Special Issue Editor


E-Mail Website
Guest Editor
Center for Rare Diseases and Congenital Defects “Fondazione Policlinico Universitario A. Gemelli, IRCCS”, Roma, Italy
Interests: syndromic obesity; Prader-Willi syndrome; obesity; bariatric surgery; diabetes; genetic obesity

Special Issue Information

Dear Colleagues,

It is with pleasure I announce the Special Issue for Nutrients entitled “Nutrition and Obesity Management in Prader–Willi syndrome and Other Forms of Genetic Obesity” that aims to cover the most recent understandings and discoveries on the prevention of obesity and treatment of hyperphagia in these patients.

Genetic obesity includes severe and rare forms of early-onset obesity caused by mutations in a single gene (monogenic obesity) and by dysregulated hunger satiety circuits in the hypothalamus (the mutation in the melanocortin-4 receptor gene (MC4R) is the most common form). In this context, there are “syndromic obesities” where obesity occurs in the presence of mental delays, dysmorphic features, short stature, organ-specific abnormalities, hyperphagia, and/or other signs of hypothalamic dysfunction (Prader–Willi syndrome, Bardet-Biedl syndrome, Alström syndrome, Rohhadnet syndrome, etc.).

Prader–Willi syndrome (PWS) is the most common form of syndromic obesity occurring in about 1:25,000 live births due to the loss of expression of paternal alleles in the PWS region of chromosome 15. These genetic anomalies lead to a well-described clinical phenotype that includes hypotonia, hypothalamic dysfunction, behavior and psychiatric problems, and the development of life-threatening obesity. Constant and obsessive food-seeking behavior can make life very difficult both for the family and caretakers. Moreover, PWS subjects die prematurely from complications conventionally related to obesity.

Consequently, dietary restriction, strict control over access to food, continuous lifelong supervision, and regular physical activity are still the only available options in all genetic obesity.

Up to now, no drugs have proven to be effective in controlling appetite but current ongoing clinical trials with new drugs seem to be encouraging. The long-term safety and effectiveness of bariatric surgery in PWS patients and syndromic obesity with life-threatening comorbidities remain unknown.

This Special Issue welcomes original research articles and reviews of the literature by researchers and study groups who work every day in this field.

I look forward to receiving your contributions.

Dr. Antonino Crinò
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Prader–Willi syndrome
  • genetic obesity
  • obesity
  • nutrition
  • dietary intake
  • hyperphagia
  • food management

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

25 pages, 4210 KiB  
Article
Dietary Conjugated Linoleic Acid Reduces Body Weight and Fat in Snord116m+/p− and Snord116m−/p− Mouse Models of Prader–Willi Syndrome
by Brittney Knott, Matthew A. Kocher, Henry A. Paz, Shelby E. Hamm, William Fink, Jordan Mason, Robert W. Grange, Umesh D. Wankhade and Deborah J. Good
Nutrients 2022, 14(4), 860; https://doi.org/10.3390/nu14040860 - 18 Feb 2022
Cited by 2 | Viewed by 3355
Abstract
Prader–Willi Syndrome (PWS) is a human genetic condition that affects up to 1 in 10,000 live births. Affected infants present with hypotonia and developmental delay. Hyperphagia and increasing body weight follow unless drastic calorie restriction is initiated. Recently, our laboratory showed that one [...] Read more.
Prader–Willi Syndrome (PWS) is a human genetic condition that affects up to 1 in 10,000 live births. Affected infants present with hypotonia and developmental delay. Hyperphagia and increasing body weight follow unless drastic calorie restriction is initiated. Recently, our laboratory showed that one of the genes in the deleted locus causative for PWS, Snord116, maintains increased expression of hypothalamic Nhlh2, a basic helix–loop–helix transcription factor. We have previously also shown that obese mice with a deletion of Nhlh2 respond to a conjugated linoleic acid (CLA) diet with weight and fat loss. In this study, we investigated whether mice with a paternal deletion of Snord116 (Snord116m+/p−) would respond similarly. We found that while Snord116m+/p− mice and mice with a deletion of both Snord116 alleles were not significantly obese on a high-fat diet, they did lose body weight and fat on a high-fat/CLA diet, suggesting that the genotype did not interfere with CLA actions. There were no changes in food intake or metabolic rate, and only moderate differences in exercise performance. RNA-seq and microbiome analyses identified hypothalamic mRNAs, and differentially populated gut bacteria, that support future mechanistic analyses. CLA may be useful as a food additive to reduce obesity in humans with PWS. Full article
Show Figures

Graphical abstract

Back to TopTop